Parkinson's Disease News From Medical News Today Latest Health News and Medical News posted throughout the day, every day.
Years Of Smoking Associated With Lower Parkinson's Risk, Not Number Of Cigarettes Per Day
Researchers have new insight into the relationship between Parkinson's disease and smoking. Several studies have shown that smokers have a lower risk of developing Parkinson's disease...
Michael J. Fox To Be Made Honorary Doctor At Karolinska Institutet
Since 2000, the foundation has awarded over 175 million dollars to Parkinson's drug development research around the world, including at Karolinska Institutet. Michael J. Fox is to receive his honorary doctorate on 5 March from Associate Professor and Dean Clara H. Gumpert representing the Board of Research, which selects the honorary doctors at Karolinska Institutet...
Psychosurgery Makes Gentle Comeback
Psychosurgery is making a comeback. Recently published case series have shown encouraging results of so-called deep brain stimulation (DBS) in treatment-resistant obsessive-compulsive disorder, depressive disorders, and Tourette syndrome...
Parkinson's Disease Makes It Harder To Figure Out How Other People Feel
Scientists are beginning to find out why people with Parkinson's disease often feel socially awkward. Parkinson's patients find it harder to recognize expressions of emotion in other people's faces and voices, report two studies published by the American Psychological Association...
Michael J. Fox Foundation Awards Mayo Clinic Researcher Grant To Advance Parkinson's Disease Research
For his work contributing to a potential new treatment approach for Parkinson's disease, the Michael J. Fox Foundation (MJFF) for Parkinson's Research has awarded a $500,000 grant to a neuroscientist at the Mayo Clinic campus in Florida. The researcher, Matthew Farrer, Ph.D...
Neuroscientist Steers Research Into Neurological Disorders
Scientists at the Queensland Brain Institute have uncovered a vital clue into how the brain is wired, which could eventually steer research into nervous system disorders such as Parkinson's disease and cognitive disorders including autism. It's long been known that growing nerve fibres, also known as axons, must make connections in the brain for it to function properly...
Researchers Take Next Step In Developing Parkinson's Disease Vaccine
Researchers at the University of Nebraska Medical Center have taken a significant step forward in developing a vaccination approach to reverse the neurological damage seen with Parkinson's disease. The findings appear in the March 1 issue of the Journal of Immunology, a leading scientific journal in the field of immunology...
FDA Approves Once-Daily MIRAPEX ER For The Treatment Of Early Parkinson's Disease
Boehringer Ingelheim Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ERВ® (pramipexole dihydrochloride) extended-release tablets, a new once-daily treatment option for the signs and symptoms of early idiopathic Parkinson's disease (PD). MIRAPEX ER is not indicated in advanced PD...
Biophysicists Show That 'Incomplete Penetrance' Is Not Just A Question Of Nature Versus Nurture
For years, biologists have wondered how it is possible that not every person who carries a mutated gene expresses the trait or condition associated with the mutation. This common but poorly understood phenomenon, known as incomplete penetrance, exists in a wide range of organisms, including humans...
An Ibuprofen A Day Could Keep Parkinson's Disease Away
New research shows people who regularly take ibuprofen may reduce their risk of developing Parkinson's disease, according to a study released that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010. The research involved 136,474 people who did not have Parkinson's disease at the beginning of the research...
Researchers Firm-Up Evidence For Role Of Mitochondria In Parkinson's Disease
A new study from the National Institutes of Health sheds light on the functions of two proteins related to Parkinson's disease, called parkin and PINK1...
Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study Of Amigal(TM) For Fabry Disease
Amicus Therapeutics (Nasdaq: FOLD) announced additional positive preliminary data from its ongoing Phase 2 extension study of its investigational drug Amigalв„ў (migalastat HCl) for Fabry disease at the Lysosomal Disease Network WORLD Symposium in Miami, Florida...
Nerve Cells In Parkinson's Disease Suffer Communication Breakdown
A new study from The Montreal Neurological Institute and Hospital - The Neuro - at McGill University is the first to discover a molecular link between Parkinson's disease and defects in the ability of nerve cells to communicate...
Industrial Cleaner Linked To Increased Risk Of Parkinson's Disease
Workers exposed to tricholorethylene (TCE), a chemical widely used to clean metal such as auto parts, may be at a significantly higher risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010...
TGen Finalizes Alliance With Van Andel Research Institute
The Translational Genomics Research Institute (TGen) has announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute (VARI) that will maximize the research capabilities of both non-profit institutes...
The Quick And The Dead: Evidence That Movement Is Swiftest In Response To Events In The Environment
Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust at the University of Birmingham have carried out "laboratory gunfights" to show that we move faster when we react to something in our environment than we do when we initiate the action ourselves- an idea inspired by cowboy movies but in reality more useful for avoiding oncoming traffic...
Parkinson's Disease Research Uncovers Social Barrier
People with Parkinson's disease suffer social difficulties simply because of the way they talk, a McGill University researcher has discovered. Marc Pell, at McGill's School of Communication Sciences and Disorders, has learned that many people develop negative impressions about individuals with Parkinson's disease, based solely on how they communicate...
Simulation Study May Help Parkinson's Patients Retain Driving Skills
In a first-of-its-kind study, Medical College of Georgia researchers are testing whether simulation driving can reduce Parkinson's patients' threefold increased risk of car accidents. Drivers with Parkinson's disease are three times more likely to have a car accident than healthy drivers because of cognitive, motor and visuospatial impairments...
Gordon Brown Receives Prescription Promise 'Wake-Up Call', UK
People across England will be joining forces to demonstrate their outrage at Gordon Brown's failure to act on his promise to abolish prescription charges for people with long-term conditions, by taking part in a simultaneous 'wake-up phone call' to No 10...
Synosia Announces Positive Interim Results For Potential First-in-Class Treatment For Parkinson's Disease
Synosia Therapeutics announced interim positive data from a Phase IIa clinical study of an adenosine 2a (A2a) receptor antagonist (SYN115) in Parkinson's disease. The Phase IIa trial was a randomised, double-blind, placebo-controlled, cross-over study in 24 Parkinson's patients using doses up to 120mg/day for one week...
Parkinson's Rates Highest In Whites, Hispanics
The largest epidemiological study of Parkinson's disease in the United States has found that the disease is more common in the Midwest and the Northeast and is twice as likely to strike whites and Hispanics as blacks and Asians...
'Deep Brain Stimulation' For Parkinson's Disease: Study By Scott & White Healthcare Researchers
At Scott & White Memorial Hospital, a multi-disciplinary team of neurosurgeons, neurologists, neurophysiologist, neuropsychologists and a movement disorders specialist are offering hope to some Parkinson's patients with a treatment called Deep Brain Stimulation (DBS)...
Lefkowitz, BBVA Foundation Frontiers Of Knowledge Award In Biomedicine
The BBVA Foundation Frontiers of Knowledge Award in the Biomedicine category goes in this second edition to Prof. Robert J. Lefkowitz (1943, New York, United States), investigator in the Department of Medicine at Duke University (United States)...
The Emergence Of A New Class Of Brain-Protecting Drugs
Researchers have identified a compound that mimics one of the brain's own growth factors and can protect brain cells against damage in several animal models of neurological disease. 7,8-dihydroxyflavone is a member of the flavonoid family of chemicals, which are abundant in fruits and vegetables...
Study Finds Common Heart Medications May Also Protect Against Parkinson's Disease
UCLA researchers have discovered that a specific type of medication used to treat cardiovascular conditions such as hypertension, angina and abnormal heart rhythms may also decrease the risk of developing Parkinson's disease. In the first large-scale population-based study of its kind, Dr...
Worlds Best Pharmacy
canadian meds shop
Why is your product so cheap? How do you ship orders? We accept : Visa, MasterCard, AmEx, Diners and JCB cards. |
